{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:30:31Z","timestamp":1789047031463,"version":"build-2803163510"},"reference-count":52,"publisher":"American Chemical Society (ACS)","issue":"17","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Z1A DA000389"],"award-info":[{"award-number":["Z1A DA000389"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Z1A DA000606"],"award-info":[{"award-number":["Z1A DA000606"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Z1A DA000611"],"award-info":[{"award-number":["Z1A DA000611"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dependence on psychostimulants, including cocaine and methamphetamine, is driving the fourth wave of U.S. drug overdoses. The search for atypical dopamine transporter (DAT) inhibitors for the treatment of psychostimulant use disorders has identified both structurally and pharmacologically diverse compounds that bind DAT but do not produce cocaine-like behaviors in experimental animals. Nevertheless, low binding affinity at hDAT, metabolic instability and high potency in the human ether-a\u0300-go-go-related gene (hERG) channel have limited further development. Herein, we describe the synthesis of a novel series of aryl-substituted-(biphenyl)methyl-sulfinylmethylthiazoles and identify two lead molecules, 32b and 39b that bind hDAT (Ki = 63.0 and 78.5 nM, respectively) and have hERG channel activities predicted to be in the low \u03bcM range. Despite demonstrated brain penetrability and target engagement neither compound produced cocaine-like locomotor stimulation or conditioned place preference, in mice, thus representing a new class of atypical DAT inhibitors and potential leads for pharmacotherapeutic development.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01907","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:02:35Z","timestamp":1786723355000},"page":"20894-20910","source":"Crossref","is-referenced-by-count":0,"title":["A Series of\nAryl-Substituted-(biphenyl)methyl-sulfinylmethylthiazoles\nas Novel and Atypical Dopamine Transporter Inhibitors"],"prefix":"10.1021","volume":"69","author":[{"given":"Gisela A.","family":"Camacho-Hernandez","sequence":"first","affiliation":[{"name":"National Institutes of Health , , 333 Cassell Drive , , ,","place":["Baltimore, Maryland, United States, 21224"]},{"name":"University of Texas Medical Branch , , , ,","place":["Galveston, Texas, United States, 77555"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjing","family":"Cao","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 333 Cassell Drive , , ,","place":["Baltimore, Maryland, United States, 21224"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarachi","family":"Okorom","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 333 Cassell Drive , , ,","place":["Baltimore, Maryland, United States, 21224"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8976-5039","authenticated-orcid":true,"given":"Carolyn J.","family":"Straub","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 333 Cassell Drive , , ,","place":["Baltimore, Maryland, United States, 21224"]},{"name":"University of Illinois Chicago , , 833 S Wood Street , , ,","place":["Chicago, Illinois, United States, 60612"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Kerr","sequence":"additional","affiliation":[{"name":"Naval Research Laboratory , Code 6920, 4555 Overlook Ave. , , ,","place":["Washington, District of Columbia, United States, 20375"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo Hao","family":"Lee","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 333 Cassell Drive , , ,","place":["Baltimore, Maryland, United States, 21224"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaela","family":"Melton","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 333 Cassell Drive , , ,","place":["Baltimore, Maryland, United States, 21224"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Maras","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 333 Cassell Drive , , ,","place":["Baltimore, Maryland, United States, 21224"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Adamson","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 333 Cassell Drive , , ,","place":["Baltimore, Maryland, United States, 21224"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4059-2453","authenticated-orcid":true,"given":"Rana","family":"Rais","sequence":"additional","affiliation":[{"name":"The Johns Hopkins University School of Medicine , , 855 North Wolfe Street , , ,","place":["Baltimore, Maryland, United States, 21205"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley N.","family":"Jackson","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 251 Bayview Blvd. , , ,","place":["Baltimore, Maryland, United States, 21224"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4137-096X","authenticated-orcid":true,"given":"Lei","family":"Shi","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 333 Cassell Drive , , ,","place":["Baltimore, Maryland, United States, 21224"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Tanda","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 333 Cassell Drive , , ,","place":["Baltimore, Maryland, United States, 21224"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Xiong","family":"Xi","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 333 Cassell Drive , , ,","place":["Baltimore, Maryland, United States, 21224"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9065-4072","authenticated-orcid":true,"given":"Amy Hauck","family":"Newman","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 333 Cassell Drive , , ,","place":["Baltimore, Maryland, United States, 21224"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"1","key":"2026091008461286000_cit1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1151\/spp05314","article-title":"The neurobiology\nof cocaine addiction","volume":"3","author":"Nestler","year":"2005","journal-title":"Sci. Pract. Perspect."},{"key":"2026091008461286000_cit2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1749-6632.2009.05148.x","article-title":"Regulation\nof the dopamine transporter: aspects relevant\nto psychostimulant drugs of abuse","volume":"1187","author":"Schmitt","year":"2010","journal-title":"Ann. N. Y.\nAcad. Sci."},{"issue":"4","key":"2026091008461286000_cit3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of\nillicit fentanyls, stimulants and the fourth wave of the opioid overdose\ncrisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"issue":"4","key":"2026091008461286000_cit4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2105\/AJPH.2024.307948","article-title":"The Fourth Wave\nof the Opioid Epidemic: Increasing Combination of Fentanyl With Stimulants","volume":"115","author":"Diekhans","year":"2025","journal-title":"Am. J. Public Health"},{"issue":"3","key":"2026091008461286000_cit5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1124\/mol.107.039800","article-title":"Relationship between conformational\nchanges in the\ndopamine transporter and cocaine-like subjective effects of uptake\ninhibitors","volume":"73","author":"Loland","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"2026091008461286000_cit6","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nn.2146","article-title":"The binding sites\nfor cocaine and\ndopamine in the dopamine transporter overlap","volume":"11","author":"Beuming","year":"2008","journal-title":"Nat. Neurosci."},{"issue":"8025","key":"2026091008461286000_cit7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41586-024-07804-3","article-title":"Structure of the\nhuman dopamine transporter in complex with cocaine","volume":"632","author":"Nielsen","year":"2024","journal-title":"Nature"},{"key":"2026091008461286000_cit8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.coph.2020.07.007","article-title":"Modafinil\nand its structural analogs as atypical dopamine uptake inhibitors\nand potential medications for psychostimulant use disorder","volume":"56","author":"Tanda","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"2026091008461286000_cit9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.biopsych.2012.03.022","article-title":"R-modafinil (armodafinil):\na unique\ndopamine uptake inhibitor and potential medication for psychostimulant\nabuse","volume":"72","author":"Loland","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"15","key":"2026091008461286000_cit10","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1021\/jm00041a002","article-title":"Novel 3 alpha-(diphenylmethoxy)tropane\nanalogs: potent dopamine uptake inhibitors without cocaine-like behavioral\nprofiles","volume":"37","author":"Newman","year":"1994","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026091008461286000_cit11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0022-3565(24)37956-X","article-title":"Novel 3alpha-diphenylmethoxytropane\nanalogs: selective dopamine uptake inhibitors with behavioral effects\ndistinct from those of cocaine","volume":"288","author":"Katz","year":"1999","journal-title":"J. Pharmacol.\nExp. Ther."},{"issue":"5","key":"2026091008461286000_cit12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/med.10014","article-title":"Probes for the dopamine transporter:\nnew leads toward\na cocaine-abuse therapeutic--A focus on analogues of benztropine and\nrimcazole","volume":"22","author":"Newman","year":"2002","journal-title":"Med. Res. Rev."},{"key":"2026091008461286000_cit13","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev-pharmtox-030220-124205","article-title":"New Drugs, Old Targets:\nTweaking the Dopamine System to Treat Psychostimulant Use Disorders","volume":"61","author":"Newman","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"8","key":"2026091008461286000_cit14","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/s41386-019-0366-z","article-title":"Translating the atypical dopamine\nuptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant\nuse disorders","volume":"44","author":"Newman","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"2026091008461286000_cit15","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1021\/jm401754x","article-title":"Elucidation of structural elements for selectivity\nacross monoamine transporters: novel 2-[(diphenylmethyl)sulfinyl]acetamide\n(modafinil) analogues","volume":"57","author":"Okunola-Bakare","year":"2014","journal-title":"J. Med. Chem."},{"issue":"23","key":"2026091008461286000_cit16","doi-asserted-by":"publisher","first-page":"10676","DOI":"10.1021\/acs.jmedchem.6b01373","article-title":"Novel and\nHigh Affinity\n2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical\nDopamine Transporter Inhibitors","volume":"59","author":"Cao","year":"2016","journal-title":"J. Med. Chem."},{"issue":"5","key":"2026091008461286000_cit17","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1021\/acs.jmedchem.9b01188","article-title":"Structure-Activity\nRelationships for a Series of (Bis(4-fluorophenyl)methyl)sulfinyl\nAlkyl Alicyclic Amines at the Dopamine Transporter: Functionalizing\nthe Terminal Nitrogen Affects Affinity, Selectivity, and Metabolic\nStability","volume":"63","author":"Slack","year":"2020","journal-title":"J. Med. Chem."},{"issue":"2","key":"2026091008461286000_cit18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1021\/acsptsci.3c00322","article-title":"Series of (([1,1\u2032-Biphenyl]-2-yl)methyl)sulfinylalkyl\nAlicyclic Amines as Novel and High Affinity Atypical Dopamine Transporter\nInhibitors with Reduced hERG Activity","volume":"7","author":"Ku","year":"2024","journal-title":"ACS Pharmacol.\nTransl. Sci."},{"issue":"1","key":"2026091008461286000_cit19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1021\/acs.jmedchem.3c02037","article-title":"Modifications to 1-(4-(2-Bis(4-fluorophenyl)methyl)sulfinyl)alkyl\nAlicyclic Amines That Improve Metabolic Stability and Retain an Atypical\nDAT Inhibitor Profile","volume":"67","author":"Okorom","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026091008461286000_cit20","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03391-7","article-title":"RDS-04\u2013010: a novel atypical\nDAT inhibitor that inhibits cocaine taking and seeking and itself\nhas low abuse potential in experimental animals","volume":"15","author":"Soler-Cedeno","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"2026091008461286000_cit21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.neuropharm.2017.12.006","article-title":"Atypical dopamine transporter inhibitors\nattenuate compulsive-like methamphetamine self-administration in rats","volume":"131","author":"Tunstall","year":"2018","journal-title":"Neuropharmacology"},{"issue":"6","key":"2026091008461286000_cit22","doi-asserted-by":"publisher","DOI":"10.3390\/biom14060713","article-title":"The Structural Basis\nof the Activity Cliff in Modafinil-Based Dopamine Transporter Inhibitors","volume":"14","author":"Lee","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"2026091008461286000_cit23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1124\/jpet.122.001363","article-title":"The Effects of the Dopamine Transporter\nLigands JJC8\u2013088 and JJC8\u2013091 on Cocaine versus Food\nChoice in Rhesus Monkeys","volume":"384","author":"Rahimi","year":"2023","journal-title":"J. Pharmacol. Exp.\nTher."},{"issue":"5","key":"2026091008461286000_cit24","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1124\/mol.108.049056","article-title":"Drug binding\nto the inactivated state is necessary but not sufficient for high-affinity\nbinding to human ether-a-go-go-related gene channels","volume":"74","author":"Perrin","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"2026091008461286000_cit25","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.124.002356","article-title":"Contrasting the reinforcing effects\nof the novel dopamine\ntransport inhibitors JJC8\u2013088 and JJC8\u2013091 in monkeys:\nPotential translation to medication assisted treatment","volume":"392","author":"Allen","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"2026091008461286000_cit26","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1021\/acs.jcim.1c00856","article-title":"Toward Reducing\nhERG Affinities for DAT Inhibitors with a Combined\nMachine Learning and Molecular Modeling Approach","volume":"61","author":"Lee","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"6","key":"2026091008461286000_cit27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development\nof a central nervous system multiparameter optimization (CNS MPO)\napproach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"issue":"22","key":"2026091008461286000_cit28","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.1021\/acs.jmedchem.7b01313","article-title":"Heterocyclic\nAnalogues of Modafinil as Novel, Atypical Dopamine Transporter Inhibitors","volume":"60","author":"Kalaba","year":"2017","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026091008461286000_cit29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1021\/acs.jmedchem.9b01938","article-title":"Structure-Activity\nRelationships of Novel Thiazole-Based Modafinil Analogues Acting at\nMonoamine Transporters","volume":"63","author":"Kalaba","year":"2020","journal-title":"J. Med. Chem."},{"issue":"11","key":"2026091008461286000_cit30","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1007\/s00213-020-05625-6","article-title":"Behavioral\nand dopamine transporter binding properties of the modafinil analog\n(S, S)-CE-158: reversal of the motivational effects of tetrabenazine\nand enhancement of progressive ratio responding","volume":"237","author":"Rotolo","year":"2020","journal-title":"Psychopharmacology"},{"key":"2026091008461286000_cit31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2021.113326","article-title":"CE-123,\na novel dopamine transporter inhibitor, attenuates locomotor hyperactivity\nand improves cognitive functions in rat model of fetal alcohol spectrum\ndisorders","volume":"410","author":"Gibula-Tarlowska","year":"2021","journal-title":"Behav. Brain Res."},{"issue":"7","key":"2026091008461286000_cit32","doi-asserted-by":"publisher","DOI":"10.3390\/biom12070881","article-title":"A Novel\nand Selective Dopamine Transporter Inhibitor, (S)-MK-26, Promotes\nHippocampal Synaptic Plasticity and Restores Effort-Related Motivational\nDysfunctions","volume":"12","author":"Kouhnavardi","year":"2022","journal-title":"Biomolecules"},{"issue":"12","key":"2026091008461286000_cit33","doi-asserted-by":"publisher","first-page":"7076","DOI":"10.1038\/s41380-021-01214-x","article-title":"Reinstatement of synaptic\nplasticity in the aging brain through specific dopamine transporter\ninhibition","volume":"26","author":"Lubec","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"2026091008461286000_cit34","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1021\/jacsau.3c00719","article-title":"Development of a\nFluorescently Labeled Ligand for Rapid\nDetection of DAT in Human and Mouse Peripheral Blood Monocytes","volume":"4","author":"Camacho-Hernandez","year":"2024","journal-title":"JACS Au"},{"issue":"2","key":"2026091008461286000_cit35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1124\/mol.59.2.269","article-title":"Inhibition\nof human ether-a-go-go potassium channels by cocaine","volume":"59","author":"O\u2019Leary","year":"2001","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"2026091008461286000_cit36","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0022-3565(24)29321-6","article-title":"Effects\nof cocaine and its major metabolites on the HERG-encoded potassium\nchannel","volume":"299","author":"Ferreira","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"13","key":"2026091008461286000_cit37","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/S0960-894X(01)00271-2","article-title":"[3H]MFZ 2\u201312:\na novel radioligand for the dopamine transporter","volume":"11","author":"Newman","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026091008461286000_cit38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112674","article-title":"Structure-activity\nrelationships for a series of (Bis(4-fluorophenyl)methyl)sulfinylethyl-aminopiperidines\nand -piperidine amines at the dopamine transporter: Bioisosteric replacement\nof the piperazine improves metabolic stability","volume":"208","author":"Giancola","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"2026091008461286000_cit39","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1021\/acschemneuro.8b00340","article-title":"Effects of (R)-Modafinil and Modafinil\nAnalogues on Dopamine Dynamics Assessed by Voltammetry and Microdialysis\nin the Mouse Nucleus Accumbens Shell","volume":"10","author":"Keighron","year":"2019","journal-title":"ACS Chem.\nNeurosci."},{"key":"2026091008461286000_cit40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev.ne.19.030196.001535","article-title":"Addictive\ndrugs and brain stimulation reward","volume":"19","author":"Wise","year":"1996","journal-title":"Annu. Rev.\nNeurosci."},{"issue":"11","key":"2026091008461286000_cit41","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1038\/nprot.2007.441","article-title":"Intracranial self-stimulation (ICSS)\nin rodents to study the neurobiology of motivation","volume":"2","author":"Carlezon","year":"2007","journal-title":"Nat. Protoc."},{"issue":"3","key":"2026091008461286000_cit42","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1124\/pr.112.007419","article-title":"Intracranial self-stimulation\nto evaluate abuse potential\nof drugs","volume":"66","author":"Negus","year":"2014","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"2026091008461286000_cit43","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0022-3565(24)38214-X","article-title":"Characteristics of\ndrug interactions with recombinant\nbiogenic amine transporters expressed in the same cell type","volume":"289","author":"Eshleman","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2\u20133","key":"2026091008461286000_cit44","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","article-title":"Pharmacological\nprofile of antidepressants and related compounds at human monoamine\ntransporters","volume":"340","author":"Tatsumi","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"2026091008461286000_cit45","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/syn.890040415","article-title":"Cocaine receptors: in vivo labeling\nwith 3H-(\u2212)cocaine, 3H-WIN 35,065\u20132, and 3H-WIN 35,428","volume":"4","author":"Scheffel","year":"1989","journal-title":"Synapse"},{"issue":"39","key":"2026091008461286000_cit46","doi-asserted-by":"publisher","first-page":"12590","DOI":"10.1021\/bi00039a014","article-title":"Heterogeneity of antidepressant binding sites on the recombinant\nrat serotonin transporter SERT1","volume":"34","author":"Schloss","year":"1995","journal-title":"Biochemistry"},{"issue":"6","key":"2026091008461286000_cit47","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1046\/j.1471-4159.1998.70062545.x","article-title":"Distinct effects of imipramine on\n5-hydroxytryptamine uptake mediated by the recombinant rat serotonin\ntransporter SERT1","volume":"70","author":"Sur","year":"1998","journal-title":"J. Neurochem."},{"key":"2026091008461286000_cit48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115674","article-title":"Neutral sphingomyelinase 2 inhibitors based on the\npyrazolo[1,5-a]pyrimidin-3-amine scaffold","volume":"259","author":"Novotna","year":"2023","journal-title":"Eur.\nJ. Med. Chem."},{"issue":"11","key":"2026091008461286000_cit49","doi-asserted-by":"publisher","first-page":"6028","DOI":"10.1021\/acs.jmedchem.0c00278","article-title":"Novel Human\nNeutral Sphingomyelinase 2 Inhibitors as Potential Therapeutics for\nAlzheimer\u2019s Disease","volume":"63","author":"S\u030ca\u0301la","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026091008461286000_cit50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12399-z","article-title":"CB1 Receptor\nActivation on VgluT2-Expressing Glutamatergic Neurons Underlies Delta(9)-Tetrahydrocannabinol\n(Delta(9)-THC)-Induced Aversive Effects in Mice","volume":"7","author":"Han","year":"2017","journal-title":"Sci. Rep."},{"issue":"46","key":"2026091008461286000_cit51","doi-asserted-by":"publisher","first-page":"8853","DOI":"10.1523\/JNEUROSCI.0988-20.2020","article-title":"Dissecting the Role\nof GABA Neurons\nin the VTA versus SNr in Opioid Reward","volume":"40","author":"Galaj","year":"2020","journal-title":"J. Neurosci."},{"issue":"4","key":"2026091008461286000_cit52","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13005","article-title":"Optogenetic brain-stimulation reward: A new procedure to re-evaluate\nthe rewarding versus aversive effects of cannabinoids in dopamine\ntransporter-Cre mice","volume":"26","author":"Humburg","year":"2021","journal-title":"Addict. Biol."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01907","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/17\/20894\/66550293\/acs.jmedchem.6c01907.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/17\/20894\/66550293\/acs.jmedchem.6c01907.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:03:20Z","timestamp":1789045400000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/17\/20894\/5255767\/A-Series-of-Aryl-Substituted-biphenyl-methyl"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":52,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,8,14]]},"published-print":{"date-parts":[[2026,9,10]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01907","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}